_id

690daf02ccc777a4e85d0ad1

Ticker

ANIX

Name

Anixa Biosciences Inc

Exchange

NASDAQ

Address

3150 Almaden Expressway, San Jose, CA, United States, 95118

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.anixa.com

Description

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the most lethal form of breast cancer; and the development of a vaccine against ovarian cancer, as well as a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Last Close

3.58

Volume

209858

Current Price

3.26

Change

-8.938547486033526

Last Updated

2025-11-28T12:14:50.883Z

Image

data:image/webp;base64,UklGRvgFAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSD0EAAANoGRt25pMemI4RL/AH8qrttFb7nlvpqSxEDckPgDeBFqHETEB+J9yIQ95rn3EtfklvbzUiLEBDwLfFifPa19oon1cCzXol+/fLy+kmaYCgCfwYr3fRtXL8O9WMbqOjRH84GVmb+qhE6Zs7h1eZcaGTdmNWxuhnb/IipU5elyycxC9xuAd89DnQh40YfQSirkIe4Emj/3jK+gGn6Nf0dL8Q/UCa/Pc9IQ3lrrZ8yaW5qBvVeGL4PQsSVXH594EYyYG7rPYsk7R/3Cluvv2SR9YgmdaLHIuz5GXC+cphtqc/eIZE20mlqS2acHzlKExRug/4215PYOcJldeUSmYmLK7fwL/wfRBd92cX65IvGUEdtGfoU86NNttOVxbAgWmViZ+05eqDhvQM9utRwabkma6WEdRX+9WaUnL3BI8z0n6mIK5MXPtnobvDAd02x0NkJ5yjZGkle7v614ktpAyWrl1GJAfA2ZxFKz0Sxj2Ymh8DnropCrQ7j1lOSKpGvI47YF7vwoamu81QwDwAmGqSxROUceu08PUUo+g75wJf3MJrlA1CkZLxdt1m7Jxm9POB9/E3ZOTmG8kWHrqp52WrLqCXIbBdXKvPniqJZF0vT6FeQfpnemB7h7FGR46/nCh8RRJnUue10FeLvwOfzoLPE7CSlRkCmZs7u1pqiEWLS12EkZA4mfmkoS1ETtnkmVeapDPQVpLlMIO9DVPYiyPopowtnQX9MNxPAHZ9iaaQpqoIy4IHgmqPslo9cbRQA9CjJQpBbI29exHjLUnkFsvOOsdmii6Mkbi1kZgFw/emynoUXjl0fXiRMaahCU7+/EdaWLKToftcT7ohL03ZzOSrEhVGN+85yZSTsu3HkN33xNn6oDCafLIP9781kQZyJdDXHA95FFW6QYFoqX5+/qmdkCPknaEPlMvNSwSVmbiZQC+NUmHRnr/YTBsuXt8m3h2AAA7TzHHJFXl8uAMcKgEmjj/8mlQc+09ocmCza4F4LojReEpkj4VAg/4Q7DWMmkmq3O+wcMWw9benQBk8RWaSsFoqbr7Fr8LzNIWlOl8PABVmI5iLy4BhNFZX5GwZpF9xc/GSd9/lQjdR9qYCwIAzc7X3iSSoVVnv7xefx3Ye13oDzN97tkAYLszfUEa6SOEAeC6Yf3h0xO4tR7aBYA4qkR1QcGULdwD0By3wdvneX8w2TmIATR+UugmibeMwAaAzaEYfWT9LWSpDhMA5SEwLJ4CU89PN5etd7W+SL1x2nwUOABwcGQ2JcmK1N6g+rGX9I+jviB9VZ1NAcCPuPGSp4At1Tvw/rwI5meuL8gsC25K71QtLBKM1T1kf24KDKt++EZmplwDwPXPTc6J5SOhMc0H2PwIL63QT8uNlU8LoQbQ/voRFy33qOFU9VGe+WHN9cUN2ZDHbRLGWSM8ajlRfIQ6iiv03eJxeUlPLf5dAgBWUDgglAEAAFAJAJ0BKkAAQAA+sUyaSacsIiEx9VyRgBYJaAC9x99E8Co+BtnOen01zeeCI1RyjwsO5hZUgpEYTubCUC5afHfn6kjUedB/iIzZp09kA1CcMOQoAP77/VOP+AI/RpujOeYqowdsHUqpfSRUP0o2rd01t8AGdOxv5F/brnCDaRDWA/ENW9oo2347taH+lreGe7Z/8EInJF/rfyAkc9Vp3QmgM7YMSiN1woQ8wDnNq4aV8Iy3zYc6b8YxVQfKKvo4N1pr8Tf/5DYSdW0FYhL4yAh3fXX/TZWmBV7kzwGIUpTcLXnGqy7xEa4ZzYG2CpEKrI462NILm2yC41W/ohc7+fOazT0GM5sq98ZBTZ5R9ZZhMVkdy/plH694L6a0nAynxBxcE8dNfuDOaQ9OIAAvCKdpbOz/0+KAlY8luNJD1FGZWOiqC7i6FWJJKS8QZPHPNJljhqrMYNFbpcJJAf556321rW1Eg3d3Zhn3XxqP7ErBGZWz7/kbQ7RrlebylSQ/WVLspndlb6NOkcpck1cIXOV4AAAA

Ipo Date

1987-01-01T00:00:00.000Z

Market Cap

152734480

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9924999999999999

Sentiment Sources

2

Rating

4.3333

Target Price

10

Strong Buy

1

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-07-31

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

2436000

Operating Income

-2436000

Interest Expense

-

Pretax Income

-2280000

Net Income

-2258000

Eps

-0.06952826702795911

Dividends Per Share

-

Shares Outstanding

32916915

Income Tax Expense

-

EBITDA

-2436000

Operating Margin

-

Total Other Income Expense Net

-

Cash

1495000

Short Term Investments

14534000

Receivables

0

Inventories

-

Total Current Assets

17449000

Property Plant Equipment

202000

Total Assets

17651000

Payables

276000

Short Term Debt

39000

Long Term Debt

-

Total Liabilities

2240000

Equity

16595000

Depreciation

168000

Change In Working Capital

363000

Cash From Operations

-1511000

Capital Expenditures

0

Cash From Investing

-833000

Cash From Financing

1929000

Net Change In Cash

-415000

PE

-

PB

6.379738475444411

ROE

-13.60650798433263

ROA

-12.792476346949181

FCF

-1511000

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-07-31

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

2436000

Quarters > 0 > income Statement > operating Income

-2436000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-2280000

Quarters > 0 > income Statement > net Income

-2258000

Quarters > 0 > income Statement > eps

-0.06952826702795911

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

32476000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-2436000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > balance Sheet > cash

1495000

Quarters > 0 > balance Sheet > short Term Investments

14534000

Quarters > 0 > balance Sheet > receivables

0

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

17449000

Quarters > 0 > balance Sheet > property Plant Equipment

202000

Quarters > 0 > balance Sheet > total Assets

17651000

Quarters > 0 > balance Sheet > payables

276000

Quarters > 0 > balance Sheet > short Term Debt

39000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

2240000

Quarters > 0 > balance Sheet > equity

16595000

Quarters > 0 > cash Flow > net Income

-2280000

Quarters > 0 > cash Flow > depreciation

168000

Quarters > 0 > cash Flow > change In Working Capital

363000

Quarters > 0 > cash Flow > cash From Operations

-1511000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-833000

Quarters > 0 > cash Flow > cash From Financing

1929000

Quarters > 0 > cash Flow > net Change In Cash

-415000

Quarters > 0 > ratios > PE

-0.06952826702795911

Quarters > 0 > ratios > PB

6.379738475444411

Quarters > 0 > ratios > ROE

-13.60650798433263

Quarters > 0 > ratios > ROA

-12.792476346949181

Quarters > 0 > ratios > FCF

-1511000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-04-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

9000

Quarters > 1 > income Statement > gross Profit

-9000

Quarters > 1 > income Statement > operating Expenses

3003000

Quarters > 1 > income Statement > operating Income

-3003000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-2813000

Quarters > 1 > income Statement > net Income

-2790000

Quarters > 1 > income Statement > eps

-0.08664058133035216

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

32202000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-2994000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

190000

Quarters > 1 > balance Sheet > cash

1910000

Quarters > 1 > balance Sheet > short Term Investments

13687000

Quarters > 1 > balance Sheet > receivables

0

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

16766000

Quarters > 1 > balance Sheet > property Plant Equipment

211000

Quarters > 1 > balance Sheet > total Assets

16977000

Quarters > 1 > balance Sheet > payables

284000

Quarters > 1 > balance Sheet > short Term Debt

37000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

2071000

Quarters > 1 > balance Sheet > equity

16068000

Quarters > 1 > cash Flow > net Income

-2813000

Quarters > 1 > cash Flow > depreciation

9000

Quarters > 1 > cash Flow > change In Working Capital

140000

Quarters > 1 > cash Flow > cash From Operations

-1503000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

2342000

Quarters > 1 > cash Flow > cash From Financing

18000

Quarters > 1 > cash Flow > net Change In Cash

857000

Quarters > 1 > ratios > PE

-0.08664058133035216

Quarters > 1 > ratios > PB

6.533390589992531

Quarters > 1 > ratios > ROE

-17.363704256908143

Quarters > 1 > ratios > ROA

-16.433998939742004

Quarters > 1 > ratios > FCF

-1503000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-01-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

3386000

Quarters > 2 > income Statement > operating Income

-3386000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-3213000

Quarters > 2 > income Statement > net Income

-3184000

Quarters > 2 > income Statement > eps

-0.09889120104357549

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

32197000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-3386000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

173000

Quarters > 2 > balance Sheet > cash

1053000

Quarters > 2 > balance Sheet > short Term Investments

16202000

Quarters > 2 > balance Sheet > receivables

0

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

18686000

Quarters > 2 > balance Sheet > property Plant Equipment

220000

Quarters > 2 > balance Sheet > total Assets

18906000

Quarters > 2 > balance Sheet > payables

600000

Quarters > 2 > balance Sheet > short Term Debt

36000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

2193000

Quarters > 2 > balance Sheet > equity

17852000

Quarters > 2 > cash Flow > net Income

-3213000

Quarters > 2 > cash Flow > depreciation

-243000

Quarters > 2 > cash Flow > change In Working Capital

-503000

Quarters > 2 > cash Flow > cash From Operations

-2904000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

2703000

Quarters > 2 > cash Flow > cash From Financing

-17000

Quarters > 2 > cash Flow > net Change In Cash

-218000

Quarters > 2 > ratios > PE

-0.09889120104357549

Quarters > 2 > ratios > PB

5.879577638359848

Quarters > 2 > ratios > ROE

-17.83553663455075

Quarters > 2 > ratios > ROA

-16.84121442928171

Quarters > 2 > ratios > FCF

-2904000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-10-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

0

Quarters > 3 > income Statement > gross Profit

0

Quarters > 3 > income Statement > operating Expenses

3163000

Quarters > 3 > income Statement > operating Income

-3163000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-2913000

Quarters > 3 > income Statement > net Income

-2883000

Quarters > 3 > income Statement > eps

-0.09038184212176312

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

31898000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-3154000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

250000

Quarters > 3 > balance Sheet > cash

1271000

Quarters > 3 > balance Sheet > short Term Investments

18653000

Quarters > 3 > balance Sheet > receivables

173000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

21362000

Quarters > 3 > balance Sheet > property Plant Equipment

229000

Quarters > 3 > balance Sheet > total Assets

21591000

Quarters > 3 > balance Sheet > payables

525000

Quarters > 3 > balance Sheet > short Term Debt

29000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

2703000

Quarters > 3 > balance Sheet > equity

19998000

Quarters > 3 > cash Flow > net Income

-2913000

Quarters > 3 > cash Flow > depreciation

9000

Quarters > 3 > cash Flow > change In Working Capital

973000

Quarters > 3 > cash Flow > cash From Operations

-927000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

867000

Quarters > 3 > cash Flow > cash From Financing

106000

Quarters > 3 > cash Flow > net Change In Cash

46000

Quarters > 3 > ratios > PE

-0.09038184212176312

Quarters > 3 > ratios > PB

5.199893989398939

Quarters > 3 > ratios > ROE

-14.416441644164415

Quarters > 3 > ratios > ROA

-13.35278588300681

Quarters > 3 > ratios > FCF

-927000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

38

Valuation > metrics > PE

-0.06952826702795911

Valuation > metrics > PB

6.379738475444411

Valuation > final Score

20

Valuation > verdict

112.7% Overvalued

Profitability > metrics > ROE

-13.60650798433263

Profitability > metrics > ROA

-12.940569660152445

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.13498041578788791

Risk > metrics > Interest Coverage

-15.615384615384615

Risk > final Score

-2

Risk > verdict

High

Liquidity > metrics > Current Ratio

55.39365079365079

Liquidity > metrics > Quick Ratio

55.39365079365079

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

21.20422361640152

Prev Valuations > 2

28.00106010601061

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-6

Prev Risks > 1

-18

Prev Risks > 2

8

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:24:37.681Z